
News|Articles|February 13, 2019
Daurismo for Newly Diagnosed AML
Author(s)Drew Boxler
Advertisement
Daurismo (glasdegib, Pfizer)
Indications: Newly-diagnosed acute myeloid leukemia (AML) in adult patients who are 75 years old or older and have comorbidities that preclude use of intensive induction chemotherapy
Dosage: 100 mg orally, once daily.
Contraindications: None
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Audits Target Pharmacies for Compliance, Revenue Recovery
2
"It is the Core of Our Oath:" Why Gender-Affirming Care Is a Fundamental Pharmacy Mandate
3
The FDA Approves Rextovy, an OTC Naloxone for Opioid Overdose
4
Pneumococcal Vaccines Fail to Clearly Protect High-Risk Adults Under 65
5

















































